39
Participants
Start Date
June 30, 2004
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Sargramostim (GM-CSF)
Starting with 3 doses of 250 micrograms subcutaneously, either pre or post vaccine. For pre vaccine, GM-CSF on days -7 (+ 1 day) and -3 (+ 1 day), in the week prior to vaccination for pre-vaccination immune priming; 3rd dose on the day of vaccination (day 0); and for post-vaccine GM-CSF given simultaneously on day of vaccination (day 0) and 2 more doses Day +3 and Day +7 after pneumococcal vaccine.
Pneumococcal Vaccine
Subcutaneously on Day 0
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Bayer
INDUSTRY
M.D. Anderson Cancer Center
OTHER